Who owns SPDR S&P Pharmaceuticals?
- Ticker: XPH
- CUSIP Number: 78464A722
Tip: Access positions for across all investors
Analyze quarterly positions in SPDR S&P Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of SPDR S&P Pharmaceuticals stock
Who bought or sold SPDR S&P Pharmaceuticals this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| Morgan Stanley | 613k | $26M | 459% | Dec 2024 |
|
| Kingsview Wealth Management | 265k | $11M | 100% | Dec 2024 |
|
| Bank of America Corporation | 257k | $11M | -8% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 143k | $6.1M | -4% | Dec 2024 |
|
| First Citizens Bank & Trust | 129k | $5.6M | 1% | Mar 2025 |
|
| LPL Financial | 128k | $5.5M | 14% | Dec 2024 |
|
| Envestnet Portfolio Solutions | 115k | $4.9M | 77% | Dec 2024 |
|
| Susquehanna International | 88k | $3.8M | 72% | Dec 2024 |
|
| Wells Fargo & Company | 86k | $3.7M | 25% | Dec 2024 |
|
| Citadel Advisors | 63k | $2.7M | 75% | Dec 2024 |
|
| Goldman Sachs Group | 61k | $2.6M | 12% | Dec 2024 |
|
| Jpmorgan Chase & Co | 53k | $2.3M | 1085% | Dec 2024 |
|
| Royal Bank of Canada | 51k | $2.2M | 105% | Dec 2024 |
|
| UBS Group | 48k | $2.0M | 19% | Dec 2024 |
|
| Wharton Business Group | 44k | $1.9M | 0% | Dec 2024 |
|
| MAI Wealth Advisors | 38k | $1.6M | -1% | Dec 2024 |
|
| Pnc Financial Services | 22k | $946k | -8% | Dec 2024 |
|
| U.S. Capital Wealth Advisors | 20k | $847k | -12% | Dec 2024 |
|
| CX Institutional | 19k | $816k | 83% | Mar 2025 |
|
| Raymond James Financial | 18k | $762k | 100% | Dec 2024 |
|
| Integrated Wealth Concepts | 17k | $712k | 1% | Dec 2024 |
|
| Ameritas Advisory Services | 10k | $430k | 1% | Dec 2024 |
|
| D. E. Shaw & Co | 8.4k | $363k | 29% | Dec 2024 |
|
| Concurrent Investment Advisors | 8.1k | $348k | 0% | Dec 2024 |
|
| Cetera Investment Advisers | 7.6k | $328k | -9% | Dec 2024 |
|
| Fragasso | 6.6k | $291k | 0% | Mar 2025 |
|
| AlphaMark Advisors | 6.6k | $285k | 7% | Dec 2024 |
|
| Bp Wealth Management | 6.2k | $267k | 100% | Dec 2024 |
|
| Captrust Financial Advisors | 5.8k | $251k | 9% | Dec 2024 |
|
| Branch Banking & Trust Company | 5.6k | $240k | 2% | Dec 2024 |
|
| Cambridge Investment Research Advisors | 5.4k | $234k | -7% | Dec 2024 |
|
| Advisor Group Holdings | 5.3k | $236k | -26% | Dec 2024 |
|
| Baird Financial | 5.3k | $227k | 0% | Dec 2024 |
|
| Sigma Planning | 5.1k | $221k | 100% | Dec 2024 |
|
| Vista Investment Management | 5.0k | $214k | 2% | Dec 2024 |
|
| Beacon Pointe Advisors | 4.9k | $211k | 100% | Dec 2024 |
|
| Janney Montgomery Scott | 4.8k | $206k | 0% | Dec 2024 |
|
| Adviser Investments | 4.8k | $206k | -4% | Dec 2024 |
|
| Commonwealth Equity Services | 4.7k | $203k | -37% | Dec 2024 |
|
| FMR | 3.9k | $167k | 3% | Dec 2024 |
|
| Atlantic Trust | 2.8k | $119k | 0% | Dec 2024 |
|
| National Bank Of Canada /fi/ | 2.8k | $118k | 0% | Dec 2024 |
|
| Bank Of Montreal | 2.4k | $103k | 5% | Dec 2024 |
|
| Us Bancorp | 2.2k | $96k | 100% | Dec 2024 |
|
| Nbc Securities | 2.1k | $93k | 107050% | Mar 2025 |
|
| Jones Financial Companies, L.L | 993.00 | $43k | 146% | Dec 2024 |
|
| Whittier Trust | 890.00 | $38k | 0% | Dec 2024 |
|
| Hanson McClain Advisors | 790.00 | $35k | 0% | Dec 2024 |
|
| Northwestern Mutual Wealth Management Company | 712.00 | $31k | 0% | Dec 2024 |
|
| Principal Securities | 615.00 | $26k | 0% | Dec 2024 |
|
| Brian McDonald | 450.00 | $19k | 0% | Dec 2024 |
|
| Federation des caisses Desjardins du Quebec | 400.00 | $17k | 0% | Dec 2024 |
|
| Lindbrook Capital | 395.00 | $17k | 0% | Dec 2024 |
|
| Castleview Partners | 242.00 | $11k | 0% | Dec 2024 |
|
| AE Wealth Management | 202.00 | $8.7k | 100% | Dec 2024 |
|
| Advantage Trust | 200.00 | $8.6k | 0% | Dec 2024 |
|
| CWM | 200.00 | $9.0k | 0% | Dec 2024 |
|
| Addison Advisors | 188.00 | $8.1k | 0% | Dec 2024 |
|
| Global Retirement Partners | 122.00 | $5.2k | 1% | Dec 2024 |
|
| Game Plan Financial Advisors | 50.00 | $2.1k | 0% | Dec 2024 |
|
| Front Row Advisors | 45.00 | $1.9k | 0% | Dec 2024 |
|
| CoreCap Advisors | 41.00 | $1.8k | -44% | Dec 2024 |
|
| McIlrath & Eck | 30.00 | $1.3k | 100% | Dec 2024 |
|
| Qube Research & Technologies | 23.00 | $989.000000 | -96% | Dec 2024 |
|
| Goss Wealth Management | 10.00 | $430.000000 | 0% | Dec 2024 |
|
| Tower Research Capital | 9.00 | $387.000000 | 200% | Dec 2024 |
|
| Creekmur Asset Management | 7.00 | $320.999700 | 0% | Dec 2024 |
|
| Creative Planning | 2.00 | $86.000000 | 100% | Dec 2024 |
|
| Huntington National Bank | 1.00 | $43.000000 | 0% | Dec 2024 |
|
| Citigroup | 1.00 | $43.000000 | -100% | Dec 2024 |
|
Who sold out of SPDR S&P Pharmaceuticals?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Clal Insurance Enterprises Holdings | Sep 2024 | 800k | $36M |
| Rockport Wealth | Sep 2024 | 28k | $1.2M |
| Gts Securities | Sep 2024 | 25k | $1.1M |
| Stifel Financial | Sep 2024 | 7.6k | $337k |
| Arlington Financial Advisors | Dec 2024 | 6.8k | $291k |
| Citizens & Northern Corporation | Sep 2024 | 6.3k | $282k |
| Jane Street | Sep 2024 | 5.8k | $259k |
| Two Sigma Securities | Sep 2024 | 4.9k | $219k |
| Angeles Wealth Management | Sep 2024 | 1.0k | $44k |
| Arrow Financial Corp. | Sep 2024 | 50.00 | $2.2k |
| Simplex Trading | Sep 2024 | 39.00 | $999.999000 |